February 13, 2024 Experience Metagenomi $93.75 million IPO The shares are listed on the Nasdaq Global Market
February 12, 2024 Experience Tenaya Therapeutics $50 million stock and pre-funded warrants offering The stock is listed on the Nasdaq Global Select Market
February 12, 2024 Experience Gilead Sciences $4.3 billion acquisition of CymaBay Therapeutics We are advising Gilead Sciences on the acquisition
February 12, 2024 Experience Eli Lilly $6.5 billion notes offering The investment-grade notes are due 2027, 2029, 2034, 2054 and 2064
February 12, 2024 Experience Deutsche Bank $1 billion notes offering The fixed-to-floating-rate eligible liabilities notes are due 2028
February 9, 2024 Experience Air Products and Chemicals $2.5 billion green notes offering The investment-grade notes are due 2029, 2031 and 2034
February 9, 2024 Experience Texas Instruments $3 billion notes offering We advised Texas Instruments on its investment-grade debt offering
February 9, 2024 Experience Owens Corning $3 billion Masonite International acquisition financing We are advising the borrower on the financing
February 9, 2024 Experience Owens Corning $3.9 billion acquisition of Masonite International We are advising Owens Corning on the acquisition
February 8, 2024 Experience Morgan Stanley $1.5 billion subordinated reset notes offering We advised Morgan Stanley on its SEC-registered global offering